Flemingsberg Science Foundation at Almedalen

We at the foundation have spent a sunny week in Almedalen 2024. It was a week filled with many insights and exciting discussions, and a highlight for us was our roundtable discussion, which we organized together with Huddinge Municipality. There, we delved into Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. Pernilla Boström, COO of the Flemingsberg Science Foundation, shares more.

“It was very inspiring to lead and participate in the roundtable discussion we organized together with Huddinge Municipality about Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. Sharing insights and experiences with a group of wise individuals from different perspectives was extremely rewarding.”

“I left Almedalen tired and satisfied, with many new impressions. I have had the privilege to participate, contribute, and be inspired alongside colleagues and partners. It has been a bustling exchange of knowledge, opportunities to influence and make a difference, and generous conversations and meetings – both formal and informal. The days were long, but I am already looking forward to next year’s Almedalen Week.”

The purpose of the roundtable discussion was to raise awareness about Flemingsberg’s development in life science and create a platform for the exchange of experiences. We shared valuable insights on how Flemingsberg can become one of Sweden’s most significant centers for education, research, and creativity. A discussion that we hope will continue even after Almedalen.

Watch our film with interviews and a summary of the discussion.

Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University's Innovation Station.

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Kick-off Cluster Engine Life Science Flemingsberg!

At the end of last year, the Flemingsberg Science Foundation was granted funding from the European Regional Development Fund (ERDF) for the project Cluster Engine Life Science Flemingsberg, which aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. Recently, it was time for the official launch – and what a grand launch it was!

Go to Top